Company intelligence / Profile preview

CardioDyme

Ownership: Private
Development stage: Preclinical

Overview

CardioDyme is developing next-generation wirelessly monitored smart implants and wearable support systems for the right heart. Their products are designed to provide efficient wireless streaming access for patient monitoring in both acute care settings and remote/home environments. The goal is to enable acute recovery and bridge-to-definitive therapy, with a pipeline aimed at supportive chronic care.

Therapeutic areas: Cardiovascular
Modalities: DeviceWearable deviceImplantable device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on CardioDyme.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CardioDyme.

Explore the full profile